sumMiARY Diamine oxidase plasma concentrations after treatment with heparin were measured and compared with the surface to volume ratio of jejunal biopsy samples assessed by a morphometric technique in patients with untreated and treated coeliac disease and in biopsied controls. As expected, enzyme activity was significantly lower in patients with untreated coeliac disease than in patients on a gluten-free diet and in biopsied controls. No difference was found betwen treated patients and biopsied controls. There was a significant overall correlation between plasma enzyme activity and surface to volume ratio of jejunal mucosa, although two untreated patients without an overt malabsorption syndrome but with a very low surface to volume ratio had nonnal enzyme activity.
This study shows that in coeliac disease plasma diamine oxidase activity after treatment with heparin does not always mirror the extent of the jejunal lesions, particularly in those patients with minimal or unrelated symptoms who would benefit most from a valid screening test to identify their condition.
Diamine oxidase is an enzyme active in the mature upper villous cells of small bowel mucosa' and found in minute quantities in all other tissues,2 except the placenta.3 After treatment with heparin diamine oxidase is released into the plasma from the intestine,4 and it was thought that measurement of diamine oxidase plasma activity after treatment with heparin could be a peripheral marker of the maturity and integrity of the small intestine epithelium. In effect, it has been shown that this measurement is a sensitive test for estimating the length of acute intestinal mucosal injury in rats'; and decreased plasma concentrations after heparin treatment have been found in patients with untreated coeliac disease,6 7a condition characterised by atrophy ofthe intestinal villi and thus by a loss of mature enterocyte mass.
In this study we attempted to verify whether plasma concentrations of diamine oxidase after heparin treatment can accurately predict the degree of jejunal damage in coeliac disease assessed by morphometry.8
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In 26 adult patients with coeliac disease the diagnosis was based on a jejunal biopsy specimen showing the histological features of villous atrophy and improvement after at least six months of a gluten-free diet. Fourteen patients were on a gluten diet (untreated) and 12 on a gluten-free diet (treated) at the time ofthe study. Seven 
Results
The table shows the results from the 33 subjects studied. Plasma values after heparin treatment were significantly lower in untreated patients than in patients on a gluten-free diet (p < 0001) and biopsied controls (p < 0 005). No significant difference was found between treated patients and biopsied controls. At the heparin doses used, no episodes of bleeding were recorded in any of the subjects studied.
With regard to the morphometric analysis ofjejunal biopsy specimens, S/V was significantly lower in untreated patients than in patients on a gluten-free diet (p < 0-001) and biopsied controls (p < 0-001). In patients on a gluten-free diet S/V was significantly lower than in biopsied controls (p < 0-005). There was no overlap between untreated and treated patients with coeliac disease. Plasma values after heparin treatment showed a significant positive correlation with S/V (figure). Two Use ofplasma diamine oxidase activities as a markerfor coeliac disease shown,6 which contrasts with our results because it implies that the test can show even barely perceptible small bowel dysfunction. Unlike our study, however, D'Agostino et al referred in their study to patients with an overt malabsorption syndrome, most of whom had severe steatorrhoea, and did not include patients with mucosal damage and normal absorption. 6 In treated coeliac disease, higher activities of diamine oxidase after heparin treatment mirror higher values of S/V and this confirms that the test indirectly assesses the recovery ofjejunal mucosa after a period on a gluten-free diet.
In conclusion, this study showed a significant overall correlation between plasma diamine oxidase activities after heparin treatment and the degree of jejunal damage assessed by morphometry in coeliac disease. In spite of this, plasma activity after heparin treatment does not always mirror the extent ofjejunal lesions, particularly in those untreated patients who are less easily suspected of having the disease due to the absence of classic malabsorption symptoms.
